Major 2026 Medicare and FDA Regulatory Changes Impacting Healthcare
Discover critical 2026 regulatory changes by CMS and FDA that will impact reimbursement, prescribing practices, and patient care throughout healthcare specialties.
Discover critical 2026 regulatory changes by CMS and FDA that will impact reimbursement, prescribing practices, and patient care throughout healthcare specialties.
Explore how federal budget cuts affect cancer research funding and the implications for health insurance coverage options amid rising treatment costs.
The surge in Medicare claims linked to transplants highlights significant fraud risks, prompting strict enforcement measures by the government to protect patients.
Explore insights on medical debt in Virginia and potential policy solutions from the Schroeder Center's latest research.
Explore the rise in Medicare Advantage denials and upcoming regulatory changes aimed at improving patient rights and healthcare access for seniors.
New Medicare initiative reduces copayments for GLP-1 medications, enhancing affordability and potentially lowering overall healthcare costs for beneficiaries.
Vermont's new Executive Order addresses high insurance costs and improves healthcare affordability through regulatory reform and legislative collaboration.
Explore the impact of treatment access on rheumatoid arthritis management, highlighting policies affecting patient care and the future of therapy pricing strategies.
Ohio sees significant ACA enrollment drop due to rising premiums and lost tax credits. Discover the impact on residents and the future of health coverage.
Discover the CMS proposed payment increase for home health agencies, aiming for enhanced compliance, improved care delivery, and fraud prevention measures.